Stay updated on TERN-501 and TERN-101 in NASH Clinical Trial
Sign up to get notified when there's something new on the TERN-501 and TERN-101 in NASH Clinical Trial page.

Latest updates to the TERN-501 and TERN-101 in NASH Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedRemoved a MedlinePlus Genetics topic: Non-alcoholic fatty liver disease, narrowing the genetics-related topic coverage.SummaryDifference0.3%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference4%

- Check30 days agoChange DetectedPage updated to version v3.1.0 and removed multiple drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) with no new substantive content added.SummaryDifference0.4%

- Check45 days agoChange DetectedAdded a MedlinePlus Genetics topic on Non-alcoholic fatty liver disease and updated the page to version v3.0.2; removed the Back to Top link.SummaryDifference0.6%

- Check52 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.2%

- Check59 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, as well as new publications related to metabolic dysfunction-associated steatohepatitis. Notably, the previous location details have been removed, indicating a shift in focus or a rebranding of the facility.SummaryDifference10%

Stay in the know with updates to TERN-501 and TERN-101 in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TERN-501 and TERN-101 in NASH Clinical Trial page.